McElroy said there are currently no clinical studies that have examined the effect of GLP-1s on symptoms of anorexia or atypical anorexia, largely because it is thought that obesity and eating disorders do not overlap in individual patients
The semaglutide group also experienced fewer fractures than the control group
November 12, 2025: Updated Sheds pricing for semaglutide and tirzepatide because they lowered their prices.
Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats
Price is important to patients, and if they can get something for $14 a month that they were getting previously for, in some cases, $900 or $1,000 a month through employer plans, where are you going to go? Hornung said